Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO). Swiss Med Wkly [Internet]. 2017 Aug. 16 [cited 2025 Nov. 4];147(3334):w14484. Available from: https://smw.ch/index.php/smw/article/view/2352